The Feasibility of HIV Vaccine Efficacy Trials among Russian Injection Drug Users

IDU exposure remains a primary driver of the Russian HIV epidemic, and recent incidence data provide little evidence that this epidemic is slowing. While there are multiple important challenges that need to be further explored before starting vaccine trials, most importantly access to evidence-based...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Beyrer, Chris, Baral, Stefan, Shaboltas, Alla, Dukhovlinova, Elena, Masharsky, Alexey, Verevochkin, Sergey, Latkin, Carl, Heimer, Robert, Hoffman, Irving, Kozlov, Andrei
Formato: Artigo
Lenguaje:Inglês
Publicado: 2007
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3747029/
https://ncbi.nlm.nih.gov/pubmed/17707960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2007.07.028
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares